China Cancer Registry Software Market Size & Outlook
China cancer registry software market, 2018-2030 (US$M)
Related Markets
China cancer registry software market highlights
- The China cancer registry software market generated a revenue of USD 3.8 million in 2023 and is expected to reach USD 10.1 million by 2030.
- The China market is expected to grow at a CAGR of 15% from 2024 to 2030.
- In terms of segment, standalone was the largest revenue generating software in 2023.
- Standalone is the most lucrative software segment registering the fastest growth during the forecast period.
Cancer registry software market data book summary
| Market revenue in 2023 | USD 3.8 million |
| Market revenue in 2030 | USD 10.1 million |
| Growth rate | 15% (CAGR from 2023 to 2030) |
| Largest segment | Standalone |
| Fastest growing segment | Standalone |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standalone, Integrated |
| Key market players worldwide | Elekta AB ADR, Health Catalyst Inc, Onconetix Inc, McKesson Corp, Rocky Mountain High Brands Inc, C/NET Solutions |
Other key industry trends
- In terms of revenue, China accounted for 5.0% of the global cancer registry software market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan cancer registry software market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 10.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Registry Software Market Scope
Cancer Registry Software Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China cancer registry software market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer registry software market will help companies and investors design strategic landscapes.
Standalone was the largest segment with a revenue share of 81.58% in 2023. Horizon Databook has segmented the China cancer registry software market based on standalone, integrated covering the revenue growth of each sub-segment from 2018 to 2030.
- China Cancer Registry Software Software Outlook (Revenue, USD Million, 2018-2030)
- Standalone
- Integrated
- China Cancer Registry Software Deployment Model Outlook (Revenue, USD Million, 2018-2030)
- On-Premise
- Cloud Based
- China Cancer Registry Software Component Outlook (Revenue, USD Million, 2018-2030)
- Commercial
- Public
- China Cancer Registry Software End-Use Outlook (Revenue, USD Million, 2018-2030)
- Government & Third Party
- Private Payers
- Hospital & Medical Practise
- Pharma Biotech & Medical Device Companies
- Research Institutes
Reasons to subscribe to China cancer registry software market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China cancer registry software market databook
-
Our clientele includes a mix of cancer registry software market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China cancer registry software market, including forecasts for subscribers. This country databook contains high-level insights into China cancer registry software market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China cancer registry software market size, by component, 2014-2030 (US$M)
China Cancer Registry Software Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
